Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/12195
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorINCA-
dc.date.accessioned2023-01-02T18:33:41Z-
dc.date.available2023-01-02T18:33:41Z-
dc.date.issued2022-03-
dc.identifier.citationINSTITUTO NACIONAL DE CÂNCER (Brasil). Entrevista Isadora Ferraz Semionatto, doutoranda do Instituto de Biologia da Unicamp. Rede Câncer, Rio de Janeiro, v. 50, p. 28-30, mar. 2022.-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/12195-
dc.descriptionp. 28-30.: il. color.pt_BR
dc.relation.ispartofseries50-
dc.subjectNeoplasias Pancreáticaspt_BR
dc.subjectPancreatic Neoplasmspt_BR
dc.subjectImunoterapia Adotiva/métodospt_BR
dc.subjectImmunotherapy, Adoptive/methodspt_BR
dc.subjectInmunoterapia Adoptiva/métodospt_BR
dc.titleEntrevista Isadora Ferraz Semionatto, doutoranda do Instituto de Biologia da Unicamppt_BR
dc.title.alternativeRede Câncer 50pt_BR
dc.TypeArticlept_BR
Appears in Collections:Rede Câncer 50

Files in This Item:
File Description SizeFormat 
Rede-cancer-2022-50-p28-30-entrevista-isadora-ferraz.pdf366.94 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.